How has COVID-19 impacted your clinical study?
Get the insights. The analysis. And the plan.
The COVID-19 pandemic has altered the clinical trial landscape around the world. Keep your study on track with expert help from the Premier Research Advanced Study Integrity Services Team (ASIST).
Premier developed ASIST to help biopharma companies like yours adapt in-process research programs to achieve optimal performance, even as conditions change. ASIST draws on Premier’s long history of successful study transitions to analyze issues, define strategies, and develop a clear path forward. Subject-matter experts across key areas of the clinical development process join forces to:
- Conduct a strategic assessment of each study that may be at risk due to COVID-19 or other trial disruptions
- Identify the root cause of risks and their probable impacts
- Develop a transition plan that leverages alternative approaches for study rescue
- Define innovative tools, technologies, and processes to aid in an efficient, effective transition
- Provide robust technical recommendations that address individual study-specific challenges